Generics 11

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Droperidol manufacturers

11 products found

Filters

11 products found

droperidol

Injection 1.25 mg/ml, 2.5 mg/ml - 1 ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Available for
Distribution only
Comments
Ref: Xomolix
Manufacturer #10720

It is one of the oldest pharmaceutical companies specializing in generic mostly for the hospital segment. The key products offered are life-saving medicines, especially in the CNS and cardiovascular therapeutic group. The company follows and complies with the EU GMP requirements.

Manufacturer usually replies in 4 days

droperidol

Solution for injection 1.25 mg/2.5 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

droperidol

Solution for injection 5 mg/ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Algeria , Angola , Bahrain , Bulgaria , Cameroon , Colombia , Egypt , Ghana , Iran , Iraq , Israel , Jordan , Kuwait , Lebanon , Libya , Lithuania , Morocco , Nigeria , Oman , Qatar , Saudi Arabia , Senegal , South Africa , Sudan , Syria , Tunisia , United Arab Emirates , Vietnam , Yemen
Manufacturer #686
A pharmaceutical manufacturer based in the EU that has been active in 100+ countries selling its products in Europe, CIS, North America, LATAM, Africa, and Asia for 30+ years. The key production line is Rx. Main therapeutic areas include antibiotics, neurology, and cardiovascular. The main dosage form is injectable. The company's production lines are GMP-compliant. The company possesses different production lines in the EU.

Manufacturer usually replies in 5 days

droperidol

Solution for infusion 1.25 mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Unavailable markets
Greece
Manufacturer #17347
It was established in the 2000s. Over the years it has become one of the major players in Europe. The commitment to work and obligation towards patients inspires the company to deliver peak performance every day. They want to help – doctors in their work and patients in their recovery. Top-quality, prompt availability, and rapid solutions – especially in critical situations – are particularly important to the company.

Manufacturer usually replies in 12 days

droperidol

Ampoules, injection 5mg in 2ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #5670

droperidol

Ampoules, injection 1.25mg/ml, 2.5mg/ml

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Manufacturer #5670

droperidol

Solution for injection 2.5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
Australia
GMP approvals
TGA
Manufacturer #13731
It is a European-owned company dedicated to providing training and job opportunities in the domains of research and development as well as commercial product production for both domestic and international markets. Over 65 drugs in essential therapeutic areas are supplied by them. It also sells and licenses items all over the world, including the Pacific, Asia, Europe, Canada, the Americas, and the Middle East

Manufacturer usually replies in 9 days

droperidol

Solution for injection 2.5 mg, 5 mg

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
EU GMP, WHO
Manufacturer #2303

Manufacturer usually replies in 6 days

droperidol

Vials 2.5 mg - 1 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
GMP, WHO
Manufacturer #24869

Manufacturer usually replies in 3 days

droperidol

Ampoules, injection 2.5 mg / ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Manufacturer #18204

Manufacturer usually replies in 9 days

droperidol

Ampoules, injection 2.5 mg/ml - 2 ml

Dossier type
CTD
Dossier status
Ready to file
Country of origin
India
GMP approvals
WHO
Available for
Licensing with supply, Distribution only
Manufacturer #18885

Manufacturer usually replies in 7 days

Droperidol Manufacturer

Droperidol is a medical substance that is a sedative, depressant, and anti-nausea medicine. It is used to decrease nausea and vomiting caused by operations or other medical methods. It may also be used for purposes not recorded in this prescription. Warnings Let your caregivers know at once if you have unexpected dizziness with fast heartbeats, trembling in your chest, or trouble in your breathing. Droperidol side effects You should get emergency medical support if you have any symptoms of an allergic reaction: hives; trouble in breathing; swelling face, lips, tongue, or throat.

How does Droperidol work?

Droperidol is mainly a butyrophenone with anti-emetic, tranquilizer, and anti-anxiety features. Although the specific mechanism through which droperidol exerts its effects is also unknown, it may hinder dopamine receptors in the chemoreceptor trigger zone (CTZ).

The Wholsale Price of Droperidol

It is obtainable in generic and brand versions. It is not covered by most Medicare and insurance plans, but pharmacy coupons can help balance the cost. In the US, The cost for droperidol injection (2.5 mg/mL) is around $182 for a supply of 50 milliliters, prices may vary on the pharmacy you visit.

Navigating our pharmaceutical marketplace

Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Droperidol offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for Droperidol manufacturers and Droperidol suppliers that you are looking for. These also enable you to check the dossier status of Droperidol, and the GMP approvals of the different variants of Droperidol. Also, each manufacturer or supplier product description contains essential information about Droperidol including clinical data, stability zones, countries where Droperidol is already registered in. Manufacturers also have special, and delivery terms.

Establishing commercial ties

If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over Ivermectin offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.

Quality Assurance

To keep up to the quality standards other than Good Manufacturing Practice approvals that Ivermectin manufacturers have, we qualify their companies before they are onboarded on the platform. This allows us to screen Ivermectin manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.